TVRD
Tvardi Therapeutics, Inc.
1.10$
-19.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | |
| – | 6.7% | 17.9% | 30.7% | 11.4% | – | |
| – | 93.3% | 82.1% | 69.3% | 88.6% | – | |
| 79.8% | 358.6% | 219.2% | 516.9% | 458.9% | – | |
| – | – | 6.5% | 13.3% | 62.4% | – | |
| 95.3% | 480.1% | 291.1% | 648.8% | 870.2% | – | |
| 4.0% | -386.8% | -209.1% | -579.4% | -781.6% | – | |
| – | – | 0.0% | 0.0% | 118.7% | – | |
| 5.7% | -384.1% | -204.2% | -565.2% | -998.5% | – | |
| -0.5% | – | – | – | -5.6% | – | |
| 6.2% | -384.1% | -204.2% | -565.2% | -993.0% | – | |
| 6.5% | -377.3% | -200.2% | -561.1% | -877.1% | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.